China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ
Closed
Oct 20, 2026
Day's Range
0.063252 wk Range
0.0400Overview - SXTC - China SXT Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
-27.15M
P/E (Trailing)
‪0.01‬
Price / Sales (TTM)
‪1.01‬
Price / Book
‪0.000044‬
EV / EBITDA
‪3.85‬
Profitability
Profit Margin
‪21.85%‬
Operating Margin
‪-153.28%‬
Return on Assets
‪-15.78%‬
Return on Equity
‪-27.48%‬
Ownership
Shares Outstanding
11.97K
Float
401.68K
Short % of Shares Outstanding
‪4.96%‬
Held by Insiders
‪15.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪1.86‬
50-Day Avg
‪2.45‬
200-Day Avg
‪690.58‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SXTC - China SXT Pharmaceuticals, Inc.
Peers - SXTC - China SXT Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NASDAQ.
Profile Summary - SXTC - China SXT Pharmaceuticals, Inc.
About
China SXT Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces. Its product lineup includes directly-oral, after-soaking-oral, fine, and regular TCMP formats, which are distributed under brands such as…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
